131 related articles for article (PubMed ID: 3047702)
1. Basic and clinical studies with corticotropin-releasing hormone. Implications for a possible role in panic disorder.
Gold PW; Pigott TA; Kling MA; Kalogeras K; Chrousos GP
Psychiatr Clin North Am; 1988 Jun; 11(2):327-34. PubMed ID: 3047702
[TBL] [Abstract][Full Text] [Related]
2. Stress responsive neurohormones in depression and anxiety.
Ströhle A; Holsboer F
Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S207-14. PubMed ID: 14677081
[TBL] [Abstract][Full Text] [Related]
3. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].
Ströhle A
Nervenarzt; 2003 Mar; 74(3):279-91; quiz 292. PubMed ID: 12627245
[TBL] [Abstract][Full Text] [Related]
4. Similarities in hypothalamic-pituitary-adrenal axis activity between patients with panic disorder and those experiencing external stress.
Kathol RG; Noyes R; Lopez A
Psychiatr Clin North Am; 1988 Jun; 11(2):335-48. PubMed ID: 3047703
[TBL] [Abstract][Full Text] [Related]
5. Panic disorder and the vestibular system.
Jacob RG
Psychiatr Clin North Am; 1988 Jun; 11(2):361-74. PubMed ID: 3047705
[TBL] [Abstract][Full Text] [Related]
6. A view on noradrenergic, hypothalamic-pituitary-adrenal axis and extrahypothalamic corticotrophin-releasing factor function in anxiety and affective disorders: the reduced growth hormone response to clonidine.
Coplan JD; Pine DS; Papp LA; Gorman JM
Psychopharmacol Bull; 1997; 33(2):193-204. PubMed ID: 9230631
[No Abstract] [Full Text] [Related]
7. Recent advances in the neurobiology of anxiety disorders: implications for novel therapeutics.
Mathew SJ; Price RB; Charney DS
Am J Med Genet C Semin Med Genet; 2008 May; 148C(2):89-98. PubMed ID: 18412102
[TBL] [Abstract][Full Text] [Related]
8. Effects of the cortisol synthesis inhibitor metyrapone on the response to carbon dioxide challenge in panic disorder.
Belgorodsky A; Knyazhansky L; Loewenthal U; Arbelle J; Cohen H; Benjamin J
Depress Anxiety; 2005; 21(3):143-8. PubMed ID: 16001448
[TBL] [Abstract][Full Text] [Related]
9. Panic disorder manifestations.
Petrone CT; Raskin DE
J Clin Psychopharmacol; 1983 Oct; 3(5):333. PubMed ID: 6630596
[No Abstract] [Full Text] [Related]
10. Corticotropin-releasing hormone and urocortin: redundant or distinctive functions?
Gysling K; Forray MI; Haeger P; Daza C; Rojas R
Brain Res Brain Res Rev; 2004 Dec; 47(1-3):116-25. PubMed ID: 15572167
[TBL] [Abstract][Full Text] [Related]
11. [Neurotransmitters in anxiety and panic disorders].
Ackenheil M
Psychiatr Prax; 1990 Jan; 17(1):23-8. PubMed ID: 1969168
[TBL] [Abstract][Full Text] [Related]
12. Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress.
Müller MB; Zimmermann S; Sillaber I; Hagemeyer TP; Deussing JM; Timpl P; Kormann MS; Droste SK; Kühn R; Reul JM; Holsboer F; Wurst W
Nat Neurosci; 2003 Oct; 6(10):1100-7. PubMed ID: 12973355
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine abnormalities in panic disorder.
Roy-Byrne PP; Uhde TW; Gold PW; Rubinow DR; Post RM
Psychopharmacol Bull; 1985; 21(3):546-50. PubMed ID: 3875875
[No Abstract] [Full Text] [Related]
14. Central CRH system in depression and anxiety--evidence from clinical studies with CRH1 receptor antagonists.
Holsboer F; Ising M
Eur J Pharmacol; 2008 Apr; 583(2-3):350-7. PubMed ID: 18272149
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine effects of ovine corticotropin-releasing hormone in panic disorder patients.
Rapaport MH; Risch SC; Golshan S; Gillin JC
Biol Psychiatry; 1989 Aug; 26(4):344-8. PubMed ID: 2548630
[TBL] [Abstract][Full Text] [Related]
16. Lack of association between the corticotrophin-releasing hormone receptor 2 gene and panic disorder.
Tharmalingam S; King N; De Luca V; Rothe C; Koszycki D; Bradwejn J; Macciardi F; Kennedy JL
Psychiatr Genet; 2006 Jun; 16(3):93-7. PubMed ID: 16691126
[TBL] [Abstract][Full Text] [Related]
17. The study of panic disorder using positron emission tomography.
Reiman EM
Psychiatr Dev; 1987; 5(1):63-78. PubMed ID: 3496592
[TBL] [Abstract][Full Text] [Related]
18. Metyrapone tests in patients with panic disorder.
Kellner M; Schick M; Yassouridis A; Struttmann T; Wiedemann K; Alm B
Biol Psychiatry; 2004 Dec; 56(11):898-900. PubMed ID: 15576069
[TBL] [Abstract][Full Text] [Related]
19. Serotonin and panic disorders: a review of clinical studies.
Norman TR; Burrows GD; Judd FK; McIntyre IM
Int J Clin Pharmacol Res; 1989; 9(2):151-7. PubMed ID: 2654037
[TBL] [Abstract][Full Text] [Related]
20. Episodic hypertension secondary to panic disorder.
White WB; Baker LH
Arch Intern Med; 1986 Jun; 146(6):1129-30. PubMed ID: 3718100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
